| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101885 1-(4-Bromo-phenyl)-3-[2-(4-methyl-piperazin-1-yl)-pyridin-3-yloxy]-pyrrolidin-2-one; antagonists of the serotonin 5HT1B receptor; treating depression |
| 09/05/2006 | US7101878 Non-peptide GNRH agents, methods and intermediates for their preparation |
| 09/05/2006 | US7101875 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/05/2006 | US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/05/2006 | US7101870 2R,3S) N1-[6,7-dihydro-5-(3-phenoxybenzyl)-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; treating Alzheimer's disease and Down's Syndrome by inhibiting production of A beta -peptide |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101867 Benzofuran derivatives, their production and use |
| 09/01/2006 | CA2499047A1 Process for producing atorvastatin hemicalcium |
| 08/31/2006 | WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 08/31/2006 | WO2006091428A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ |
| 08/31/2006 | WO2006090915A1 Pyridyl acetic acid compounds |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090717A1 Quinazoline derivative having tyrosine kinase inhibitory activity |
| 08/31/2006 | WO2006090279A1 Oxyindole derivatives as 5ht4 receptor agonists |
| 08/31/2006 | WO2006090268A2 Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin |
| 08/31/2006 | WO2006089909A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 08/31/2006 | WO2006089872A1 Glucopyranosyl-substituted ( (hetero)arylethynyl-benzyd-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 08/31/2006 | WO2006089700A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | WO2006074025B1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 08/31/2006 | WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 08/31/2006 | WO2006071750B1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | WO2006066133A3 Histone deacetylase inhibitors |
| 08/31/2006 | WO2006062984A3 Inhibitors of protein kinases |
| 08/31/2006 | WO2006035068A3 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 08/31/2006 | WO2006026368A3 Development of fluorogenic substrates for monoamine oxidases (mao-a and mao-b) |
| 08/31/2006 | WO2005120577A3 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity |
| 08/31/2006 | WO2005035507A3 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/31/2006 | US20060194962 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 08/31/2006 | US20060194866 Less toxicity; side effects redution; substituted p-chlorobenzene and a pyrrolethoxybenzene |
| 08/31/2006 | US20060194865 G-lactam derivatives as prostaglandin agonists |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194862 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 08/31/2006 | US20060194859 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/31/2006 | US20060194851 Benzofuran compound and medicinal composition containing the same |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194824 Compositions containing pyrimidine derivatives as inhibitors of cox-2 |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194816 Benzofuran derivatives useful for treating hyper-proliferative disorders |
| 08/31/2006 | US20060194804 Hiv replication inhibiting pyrimidines and triazines |
| 08/31/2006 | US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 08/31/2006 | US20060194801 inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist; N-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-4-((E)-3,3-dimethyl-but-1-enyl)-benzamide; 6-(3,3-Dimethyl-but-1-ynyl)-N-guinolin-3-yl-nicotinamide |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194795 Platelet ADP receptor inhibitors |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194783 Cgrp receptor antagonists |
| 08/31/2006 | US20060194781 Alkyl ether derivatives or salts thereof |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194772 Triamide-substituted heterobicyclic compounds |
| 08/31/2006 | CA2599454A1 Activator for peroxisome proliferator activating receptor d |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2599021A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 08/31/2006 | CA2598934A1 Pyridyl acetic acid compounds |
| 08/31/2006 | CA2598853A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | CA2598418A1 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | CA2595257A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 08/30/2006 | EP1695980A2 Human papillomavirus E2 transactivation domain / inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 08/30/2006 | EP1695966A1 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| 08/30/2006 | EP1695965A1 Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 08/30/2006 | EP1695962A1 Cyclic amine derivative having heteroaryl ring |
| 08/30/2006 | EP1695705A1 Compounds effecting glucokinase |
| 08/30/2006 | EP1694686A1 Kinase inhibitors |
| 08/30/2006 | EP1694672A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 08/30/2006 | EP1694668A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics |
| 08/30/2006 | EP1694664A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 08/30/2006 | EP1694663A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 08/30/2006 | EP1694651A1 Herbicidal pyrimidines |
| 08/30/2006 | EP1694649A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 08/30/2006 | EP1694644A2 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b |
| 08/30/2006 | EP1694642A2 Mutagenic heterocycles |
| 08/30/2006 | EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/30/2006 | EP1558745A4 Mutagenesis methods using ribavirin and/or rna replicases |
| 08/30/2006 | EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 08/30/2006 | EP1439885B1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 08/30/2006 | EP1335722B1 Indolyl-sulfonyl- compounds useful in the treatment of cns disorders |
| 08/30/2006 | EP1071681B1 Nitroxyl derivatives with glycidyl or alkylcarbonyl groups as initiators for radical polymerisation |
| 08/30/2006 | CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
| 08/30/2006 | CN1826325A 4,5-dihydro-imidazole as P2X7 ion channel blockers |
| 08/30/2006 | CN1826324A Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 08/30/2006 | CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 08/30/2006 | CN1826322A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 08/30/2006 | CN1826310A Novel aminobenzophenone compounds |
| 08/30/2006 | CN1824662A Substituted pyridine herbicides |
| 08/30/2006 | CN1272326C Phenylpyridazine derivatives and drugs containing the same |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/29/2006 | US7098340 Quinoline/chromene derivatives as androgen antagonist |